Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in medications like Wegovy and Ozempic, works through a gradual dosing schedule that helps minimize side effects while building toward your target therapeutic dose. Most patients begin at 0.25 mg weekly and progress through a 16-week titration protocol designed to reach effective weight loss doses between 1.7 mg and 2.4 mg weekly. Understanding how this progression works helps you set realistic expectations and commit fully to your personalized weight loss journey with PlexusDx.

How Semaglutide Dosing Schedules Work

Semaglutide follows a structured four-month titration schedule that increases your weekly injection dose every four weeks. Week 1–4 uses a 0.25 mg dose to allow your system to acclimate to the medication and assess tolerance. Weeks 5–8 increase to 0.5 mg, establishing stronger appetite suppression while your gastrointestinal system continues adjusting. Weeks 9–12 move to 1.0 mg, and weeks 13–16 reach 1.7 mg, which serves as the minimum maintenance dose for most patients seeking sustained weight loss.

Your body's response during each four-week phase determines whether your prescriber advances you on schedule or maintains your current dose longer. Some patients experience optimal results at 1.7 mg and never require higher doses, while others continue to 2.4 mg for enhanced satiety and metabolic effects. PlexusDx ensures your dose progresses based on your individual tolerance and weight loss response—not a one-size-fits-all timeline. Starting low and titrating upward significantly reduces nausea, vomiting, and gastrointestinal side effects compared to jumping immediately to higher doses.

Why Your Dose May Increase During Treatment

Your body gradually builds tolerance to semaglutide's appetite-suppressing effects over time, a phenomenon called desensitization. As your receptors adapt to the medication's continuous signal, you may notice increased hunger or reduced satiety at your current dose after several months of consistent use. Rather than interpreting this as medication failure, dose escalation reestablishes the therapeutic effect and prevents weight loss plateaus. Clinical trials show patients who advance to higher doses often regain momentum in their weight reduction journey.

The Precision Peptide Genetic Test available through PlexusDx can reveal your GLP1R and GIPR genetic variants, which influence how quickly your body responds to semaglutide and whether you might benefit from earlier or higher dose adjustments. Patients with certain genetic predispositions show reduced initial appetite suppression and may reach their optimal dose faster than the standard four-week progression. PlexusDx personalizes your dosing timeline by integrating your genetic insights with your clinical response, ensuring you reach maximum efficacy without unnecessary delays or overmedication.

Effective Semaglutide Doses for Weight Loss Results

Clinical research demonstrates that semaglutide produces measurable weight loss at doses as low as 0.5 mg weekly, with average reductions of 5–8% of body weight at this level. However, the most substantial and sustained weight loss typically occurs at maintenance doses of 1.7 mg to 2.4 mg weekly, where patients average 10–15% total body weight reduction after 68 weeks of treatment. The difference in efficacy between 0.5 mg and 2.4 mg represents approximately two to three times greater weight loss, making dose optimization critical for your success. Your target dose depends on your current weight, metabolism, health conditions, and personal weight loss goals.

Reaching your optimal semaglutide dose isn't just about finding the highest number—it's about discovering the dose that balances meaningful weight loss with side effects you can tolerate long-term. Many patients find their sweet spot between 1.7 mg and 2.0 mg, where appetite suppression remains strong without excessive gastrointestinal symptoms. PlexusDx providers monitor your progress during each four-week phase and may pause advancement if you experience intolerable nausea or other adverse effects, allowing you to consolidate results at your current dose. Once you stabilize at your effective dose, PlexusDx maintains flat monthly pricing—your dose may increase, but your cost remains consistent month to month.

Personalizing Your Semaglutide Dose with PlexusDx

PlexusDx compounded semaglutide injections begin at $149 per month across all dose levels, removing cost barriers that might otherwise prevent you from advancing to your optimal therapeutic dose. This flat-rate pricing model ensures you never hesitate to increase your dose when medically appropriate because price escalation won't surprise you. Your prescriber adjusts your weekly injection dose based on your weight loss trajectory, hunger levels, side effect profile, and genetic predispositions—not insurance coverage limits or cost considerations.

The Precision Peptide Genetic Test ($99 add-on after your first month of treatment) evaluates your GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 variants, revealing 150+ genetic insights across 49 peptides and 14 metabolic pathways. This genetic profile identifies whether you're a rapid responder, slow responder, or have specific genetic factors influencing appetite regulation and weight loss capacity. Armed with this data, PlexusDx crafts a personalized dosing strategy that anticipates your body's response and optimizes your progression timeline, potentially accelerating you toward your effective dose while minimizing trial-and-error adjustments.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard starting dose of semaglutide for weight loss?

Semaglutide treatment begins with a 0.25 mg weekly injection dose for the first four weeks, allowing your body to acclimate to the medication. This low starting dose significantly reduces initial side effects while establishing your baseline tolerance. PlexusDx providers then increase your dose every four weeks according to your response, progressing toward your target maintenance dose of 1.7–2.4 mg weekly.

How long does it take to reach the most effective semaglutide dose?

The standard titration schedule reaches maintenance doses within 16 weeks (four months), advancing through four incremental dose increases. However, some patients may remain at intermediate doses longer if they experience significant side effects or achieve excellent weight loss results before reaching the highest tier. PlexusDx adjusts your individual timeline based on your tolerance and clinical response rather than forcing a rigid schedule.

Does the cost of semaglutide go up when my dose increases?

No. PlexusDx compounded semaglutide injections cost $149 per month flat, regardless of whether you're taking 0.25 mg or 2.4 mg weekly. Your dose may need to go up; your price won't. This transparent pricing eliminates financial barriers to reaching your optimal therapeutic dose and prevents sticker shock during dose adjustments.

Will semaglutide stop working if I stay on it long-term?

Some patients experience tolerance development after several months, where appetite suppression gradually decreases at a constant dose. This doesn't mean semaglutide has failed—it means your receptors have adapted. Advancing to a higher dose typically restores the appetite-suppressing effect. PlexusDx monitors your weight loss progress and hunger levels to identify when dose adjustment becomes necessary and proactively manages long-term efficacy.

Can the Precision Peptide Genetic Test help determine my ideal semaglutide dose?

Yes. The Precision Peptide Genetic Test reveals your GLP1R and GIPR variants, which directly influence how your body responds to semaglutide therapy. Patients with certain genetic profiles may achieve rapid appetite suppression at lower doses, while others may require faster progression to higher doses for equivalent results. PlexusDx integrates your genetic insights with your clinical response to optimize your dosing schedule and accelerate your path to maximum weight loss effectiveness.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves